Hematopoietic stem cell transplantation | Department of Medicine Blog

A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Arslan S, Cutler C, Alousi A, Hamadani M, Abhyankar SH, Pusic I, Ross M, Schiller G, Dash A, Liu W, Yu Y, Lekkerkerker A, Wong[...]

By afschroeder • June 2, 2026

The sequelae of hematopoietic stem cell transplantation in adolescents and young adults: protocol for a systematic review

Baclig NV, Osuna-Garcia A, Chotai V, Ganz PA, Brauer ER. The sequelae of hematopoietic stem cell transplantation in adolescents and young adults: protocol for a[...]

By sjmartinez • June 16, 2024

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy

Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon[...]

By sjmartinez • March 29, 2023